Cataract Surgery

>

Latest News

First patient dosed in Phase 3 clinical trial of MELT-300, procedural sedative for patients undergoing cataract surgery
First patient dosed in Phase 3 clinical trial of MELT-300, procedural sedative for patients undergoing cataract surgery

June 6th 2024

MELT-300 is a non IV, non-opioid tablet that combines fixed doses of midazolam (3mg) and ketamine (50mg).

Prevent Blindness focusing on educating public during Cataract Awareness Month
Prevent Blindness focusing on educating public during Cataract Awareness Month

June 1st 2024

New World Medical receives 510k clearance for device for reduction of IOP in patients with POAG
New World Medical receives 510k clearance for device for reduction of IOP in patients with POAG

May 22nd 2024

Dustin Morley, PhD, speaks at the 2024 ARVO meeting
ARVO 2024: How a deep learning model can benefit femtosecond laser-assisted cataract surgery

May 7th 2024

Measuring biomarkers may Identify patients at risk of retinal vascular progression after cataract surgery
Measuring biomarkers may Identify patients at risk of retinal vascular progression after cataract surgery

April 7th 2024

Video Interviews
Podcasts
EyePod: Transforming the MIGS pipeline into clinical practice
EYEPOD: Michael Rivers, MD, discusses the impact of Aetna's new policy requiring prior authorization for cataract surgery on ophthalmologists, their workflow, and patients.

More News

© 2024 MJH Life Sciences

All rights reserved.